Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management
Condition: Loculated Empyema Intervention: Drug: Intra-pleural Alteplase 16mg with Pulmozyme (DNase) 5mg Sponsor: National University of Malaysia Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2021 Category: Research Source Type: clinical trials
A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity
Condition: Stroke Interventions: Drug: tenecteplase; Drug: alteplase Sponsor: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2021 Category: Research Source Type: clinical trials
Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management
Condition: Loculated Empyema Intervention: Drug: Intra-pleural Alteplase 16mg with Pulmozyme (DNase) 5mg Sponsor: National University of Malaysia Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2021 Category: Research Source Type: clinical trials
Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke Interventions: Drug: Dimethyl Fumarate; Drug: Placebo Sponsor: Xuanwu Hospital, Beijing Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2021 Category: Research Source Type: clinical trials
24 Hours Treatment With Alteplase in Patients With Ischemic Stroke
Condition: Stroke Intervention: Drug: Alteplase Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2021 Category: Research Source Type: clinical trials
